Edison highlights that EMIS reported flat revenue and adjusted operating profit for the year and has indicated that it expects growth to resume in 2021.

Development of the EMIS-X platform, started in 2018, positions the company well to meet the evolving needs of the healthcare sector, opening up opportunities in health data analytics and collaboration between the health and life sciences sectors.

Read the full report.

Attachments

  • Original document
  • Permalink

Disclaimer

EMIS Group plc published this content on 22 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2021 11:52:03 UTC.